Description
CagriSema is supplied for in vitro laboratory research use only.
Overview
CagriSema (cagrilintide + semaglutide) is studied in metabolic research as combined amylin-analogue and GLP‑1 receptor agonism.
Research Applications
- Appetite/satiety pathway hypotheses
- Cardiometabolic signaling studies
- Combination agonism pathway crosstalk experiments
Product Details
- Purity: ≥99% (vendor COA)
- Form: Lyophilized powder
- Quantity: see variations
Storage
Store sealed in a cool, dry environment away from direct light. Follow your laboratory’s handling SOPs.
For research use only. Not for human consumption.
